Stockscreener 앱 받기
5.45
2.46%
0.17
전일 마감가:
$5.28
열려 있는:
$5.29
하루 거래량:
19,376
Relative Volume:
0.33
시가총액:
$197.82M
수익:
$2.76M
순이익/손실:
$-49.12M
주가수익비율:
-4.621
EPS:
-1.1794
순현금흐름:
$-46.21M
1주 성능:
-12.88%
1개월 성능:
+0.00%
6개월 성능:
+5.46%
1년 성능:
-13.58%
1일 변동 폭
$5.23
$5.64
1주일 범위
$5.0093
$6.385
52주 변동 폭
$4.22
$11.69
Orchestra Biomed Holdings Inc Stock (OBIO) Company Profile
명칭
Orchestra Biomed Holdings Inc
전화
646-343-9298
주소
150 UNION SQUARE DRIVE, NEW HOPE
OBIO을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
| OBIO | 5.45 | 197.82M | 2.76M | -49.12M | -46.21M | -1.1794 |
| VRTX | 449.69 | 115.43B | 10.63B | -479.80M | -1.35B | 13.33 |
| REGN | 748.75 | 82.04B | 13.85B | 4.65B | 3.32B | 35.06 |
| ARGX | 588.46 | 35.30B | 1.86B | -40.29M | -1.28B | -4.16 |
| ALNY | 247.89 | 32.04B | 2.09B | -332.26M | 16.06M | -4.14 |
| BNTX | 106.52 | 24.89B | 3.30B | -501.07M | 1.03B | 11.54 |
Orchestra Biomed Holdings Inc Stock (OBIO) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2023-02-24 | 개시 | Piper Sandler | Overweight |
| 2023-02-07 | 개시 | Chardan Capital Markets | Buy |
Orchestra Biomed Holdings Inc 주식(OBIO)의 최신 뉴스
Orchestra BioMed to Present at Jefferies London Healthcare Conference - MSN
HC Wainwright Has Optimistic Outlook of OBIO FY2024 Earnings - Defense World
Research Analysts Offer Predictions for OBIO FY2024 Earnings - Defense World
Orchestra BioMed (NASDAQ:OBIO) Earns "Buy" Rating from HC Wainwright - MarketBeat
Chardan Capital Reaffirms Buy Rating for Orchestra BioMed (NASDAQ:OBIO) - Defense World
Orchestra BioMed Holdings Third Quarter 2024 Earnings: Beats Expectations - Yahoo Finance
We Think Orchestra BioMed Holdings (NASDAQ:OBIO) Needs To Drive Business Growth Carefully - Yahoo Finance
Orchestra BioMed Reports Q3 2024 Results, Advances Key Clinical Programs - MSN
Orchestra Biomed Reports Q3 2024 Financial Results - TipRanks
Orchestra BioMed Holdings, Inc. (OBIO) Reports Q3 Loss, Tops Revenue Estimates - Yahoo Finance
Orchestra BioMed Reports Third Quarter 2024 Financial Results and Provides a Business Update - GlobeNewswire
Orchestra BioMed Q3 Revenue Jumps 150%, Extends Cash Runway Despite Wider Losses | OBIO Stock News - StockTitan
Trading (OBIO) With Integrated Risk Controls - Stock Traders Daily
Orchestra BioMed to Participate in Jefferies London Healthcare Conference - GlobeNewswire
Orchestra BioMed Holdings, Inc.'s (NASDAQ:OBIO) market cap surged US$23m last week, individual investors who have a lot riding on the company were rewarded - Simply Wall St
(OBIO) Pivots Trading Plans and Risk Controls - Stock Traders Daily
HC Wainwright & Co. Initiates Coverage of Orchestra BioMed Holdings (OBIO) with Buy Recommendation - MSN
Orchestra BioMed Appoints John Mack to Board of Directors - MSN
SkyView Investment Advisors LLC Invests $163,000 in Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) - Defense World
Rhumbline Advisers Buys 17,405 Shares of Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) - Defense World
Insider Buying: Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) Insider Buys 2,500 Shares of Stock - MarketBeat
Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) Insider David P. Hochman Purchases 2,500 Shares - Defense World
Orchestra BioMed executive acquires shares worth over $47k By Investing.com - Investing.com Australia
Orchestra BioMed executive acquires shares worth over $47k - Investing.com India
Market Update: Ocular Therapeutix Inc (OCUL) Sees Negative Movement, Closing at 8.46 - The Dwinnex
Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) Shares Bought by Bank of New York Mellon Corp - Defense World
Ocular Therapeutix, Inc. (NASDAQ:OCUL) Shares Sold by Logos Global Management LP - MarketBeat
Elevai Labs shares tumble on pricing of new stock offering - Sacramento Business Journal
Why Elevai Labs (ELAB) Stock Is Down 60% Today - Benzinga
Elevai Labs announces pricing of $8 million public offering - MSN
Elevai Labs Inc. Announces Pricing of $8.0 Million Public Offering - GlobeNewswire
L’Oreal partners with Evonik and Abolis to scale development of next-gen ingredients - GlobalCosmeticsNews
Video: A WONDERFUL WORLD Parades to Studio 54 - BroadwayWorld
The Cure 'Songs of a Lost World' billboard appears in NYC - Brooklyn Vegan
Exicure Shares More Than Double After Nasdaq Listing Extension - MarketWatch
Oxford Biomedica Emerges as OXB with Global Vision - TipRanks
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of European Wax Center, Inc.EWCZ - PR Newswire
Ocular Therapeutix Inc’s Market Journey: Closing Weak at 8.93, Down -0.78 - The Dwinnex
(OBIO) On The My Stocks Page - Stock Traders Daily
IPO NewsUP IPO Weekly Recap: 3 Biotechs Lead Active September IPO Market - Renaissance Capital
L'Oreal, Evonik join $38.6 million funding round for biotech start-up Abolis - Fashion Network
Interactive Bible Study Course Demonstrated to Over 200 Individuals at International Fair in Angola - JW News
Orchestra BioMed executive sells over $73k in company stock - Investing.com India
Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) Director Eric S. Fain Sells 2,000 Shares of Stock - MarketBeat
Orchestra BioMed director sells over $30k in company shares - Investing.com
Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) Insider Sells $41,705.70 in Stock - Defense World
Have Orchestra BioMed Holdings Insiders Been Selling Stock? - Simply Wall St
Orchestra BioMed executive sells over $120k in company stock - Investing.com India
Insider Selling: Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) Insider Sells 6,819 Shares of Stock - MarketBeat
Orchestra BioMed executive sells over $120k in company stock By Investing.com - Investing.com UK
Orchestra BioMed Initiates BackBeat Pivotal Study Of AVIM Therapy - MPO-mag
Orchestra Biomed Holdings Inc (OBIO) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.80%
0.42%
자본화:
|
볼륨(24시간):